Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis

Cytokine ◽  
2012 ◽  
Vol 57 (1) ◽  
pp. 46-53 ◽  
Author(s):  
Obul R. Bandapalli ◽  
Franziska Ehrmann ◽  
Volker Ehemann ◽  
Matthias Gaida ◽  
Stephan Macher-Goeppinger ◽  
...  
2018 ◽  
Vol 500 (3) ◽  
pp. 731-737 ◽  
Author(s):  
Abhishek Kumar ◽  
Madhuri Cherukumilli ◽  
Seyed Hamidreza Mahmoudpour ◽  
Karsten Brand ◽  
Obul Reddy Bandapalli

2022 ◽  
Vol 272 ◽  
pp. 37-50
Author(s):  
Louis F. Chai ◽  
John C. Hardaway ◽  
Kara R. Heatherton ◽  
Kyle P. O'Connell ◽  
Jason P. LaPorte ◽  
...  

2020 ◽  
Vol 10 ◽  
Author(s):  
Nick A. van Huizen ◽  
Peter C. Burgers ◽  
Joost van Rosmalen ◽  
Michail Doukas ◽  
Jan N. M. IJzermans ◽  
...  

2014 ◽  
Vol 207 (4) ◽  
pp. 493-498 ◽  
Author(s):  
Rafael S. Pinheiro ◽  
Paulo Herman ◽  
Renato M. Lupinacci ◽  
Quirino Lai ◽  
Evandro S. Mello ◽  
...  

2020 ◽  
Author(s):  
Lungwani Muungo

A 72-year-old woman with a sigmoid colon cancer anda synchronous colorectal liver metastasis (CRLM), whichinvolved the right hepatic vein (RHV) and the inferiorvena cava (IVC), was referred to our hospital. Themetastatic lesion was diagnosed as initially unresectablebecause of its invasion into the confluence of theRHV and IVC. After she had undergone laparoscopicsigmoidectomy for the original tumor, she consequentlyhad 3 courses of modified 5-fluorouracil, leucovorin,and oxaliplatin (mFOLFOX6) plus cetuximab. Computedtomography revealed a partial response, and theconfluence of the RHV and IVC got free from cancerinvasion. After 3 additional courses of mFOLFOX6 pluscetuximab, preoperative percutaneous transhepaticportal vein embolization (PTPE) was performed tosecure the future remnant liver volume. Finally, a righthemihepatectomy was performed. The postoperativecourse was uneventful. The patient was dischargedfrom the hospital on postoperative day 13. She hadneither local recurrence nor distant metastasis 18 moafter the last surgical intervention. This multidisciplinarystrategy, consisting of conversion chemotherapy usingFOLFOX plus cetuximab and PTPE, could contributein facilitating curative hepatic resection for initiallyunresectable CRLM.Key words: Initially unresectable; Colorectal liver metastasis;Conversion chemotherapy; Cetuximab; Percutaneoustranshepatic portal vein embolization


2014 ◽  
Vol 25 (4) ◽  
pp. 608-617 ◽  
Author(s):  
Steven Y. Huang ◽  
Thomas A. Aloia ◽  
Junichi Shindoh ◽  
Joe Ensor ◽  
Colette M. Shaw ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document